Hantavirus and Arenavirus Antibodies in Persons with Occupational Rodent Exposure, North America by Fulhorst, Charles F et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Other Publications in Zoonotics and Wildlife 
Disease Wildlife Disease and Zoonotics 
2007 
Hantavirus and Arenavirus Antibodies in Persons with 
Occupational Rodent Exposure, North America 
Charles F. Fulhorst 
University of Texas Medical Branch, Galveston 
Mary Louise Milazzo 
University of Texas Medical Branch, Galveston 
Lori R. Armstrong 
Centers for Disease Control and Prevention, Atlanta, 
James E. Childs 
Centers for Disease Control and Prevention, Atlanta,, james.childs@yale.edu 
Pierre E. Rollin 
Centers for Disease Control and Prevention, Atlanta, 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.unl.edu/zoonoticspub 
 Part of the Veterinary Infectious Diseases Commons 
Fulhorst, Charles F.; Milazzo, Mary Louise; Armstrong, Lori R.; Childs, James E.; Rollin, Pierre E.; Khabbaz, 
Rima; Peters, C.J.; and Ksiazek, Thomas G G., "Hantavirus and Arenavirus Antibodies in Persons with 
Occupational Rodent Exposure, North America" (2007). Other Publications in Zoonotics and Wildlife 
Disease. 64. 
https://digitalcommons.unl.edu/zoonoticspub/64 
This Article is brought to you for free and open access by the Wildlife Disease and Zoonotics at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Other Publications in 
Zoonotics and Wildlife Disease by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. 
Authors 
Charles F. Fulhorst, Mary Louise Milazzo, Lori R. Armstrong, James E. Childs, Pierre E. Rollin, Rima 
Khabbaz, C.J. Peters, and Thomas G G. Ksiazek 
This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/
zoonoticspub/64 
Rodents are the principal hosts of Sin Nombre virus, 4
other hantaviruses known to cause hantavirus pulmonary
syndrome in North America, and the 3 North American are-
naviruses. Serum samples from 757 persons who had
worked with rodents in North America and handled
neotomine or sigmodontine rodents were tested for anti-
bodies against Sin Nombre virus, Whitewater Arroyo virus,
Guanarito virus, and lymphocytic choriomeningitis virus.
Antibodies against Sin Nombre virus were found in 4 per-
sons, against Whitewater Arroyo virus or Guanarito virus in
2 persons, and against lymphocytic choriomeningitis virus
in none. These results suggest that risk for infection with
hantaviruses or arenaviruses usually is low in persons
whose occupations entail close physical contact with
neotomine or sigmodontine rodents in North America.
Hantavirus pulmonary syndrome (HPS) is a frequentlyfatal rodentborne viral zoonosis. Seven species in the
virus family Bunyaviridae, genus Hantavirus (1), have
been causally associated with HPS: Sin Nombre virus
(SNV), New York virus (NYV), Black Creek Canal virus
(BCCV), Bayou virus (BAYV), and Choclo virus (CHOV)
in North America (2–6), and Andes virus (ANDV) and
Laguna Negra virus (LANV) in South America (7,8).
The virus family Arenaviridae, genus Arenavirus,
includes 3 North American species and 14 South American
species (9). The North American species are Bear Canyon
virus (BCNV), Tamiami virus (TAMV), and Whitewater
Arroyo virus (WWAV). The South American species
include Guanarito virus (GTOV), Junin virus (JUNV),
Machupo virus (MACV), and Sabiá virus (SABV). These
4 South American species have been causally associated
with severe human disease in Venezuela, Argentina,
Bolivia, and Brazil, respectively (10). The human health
importance of the North American arenavirus species has
not been rigorously investigated.
Specific members of the subfamilies Neotominae and
Sigmodontinae in the rodent family Cricetidae (11) are the
principal hosts (reservoirs) of the hantaviruses known to
cause HPS in North America and the 3 North American
arenaviruses. For example, principal hosts and their
respective viruses include: the deer mouse (Peromyscus
maniculatus) in Canada and the western United States,
SNV (12,13); the white-footed mouse (Peromyscus leuco-
pus) in the northeastern United States, NYV (3); the hispid
cotton rat (Sigmodon hispidus) in Florida, BCCV and
TAMV (4,14); the marsh rice rat (Oryzomys palustris) in
the southeastern United States, BAYV (15–17); the ful-
vous colilargo (Oligoryzomys fulvescens) in Panama,
CHOV (6); the California mouse (Peromyscus californi-
cus) in California, BCNV (18); and the white-throated
woodrat (Neotoma albigula) in New Mexico, WWAV (19).
P. maniculatus, P. leucopus, P. californicus, and N. albigu-
la are members of the Neotominae and S. hispidus, O.
palustris, and O. fulvescens are members of the
Sigmodontinae (11).
Hantavirus and Arenavirus
Antibodies in Persons with
Occupational Rodent Exposure,
North America
Charles F. Fulhorst,* Mary Louise Milazzo,* Lori R. Armstrong,† James E. Childs,†1
Pierre E. Rollin,† Rima Khabbaz,† C.J. Peters,†2 and Thomas G. Ksiazek†
RESEARCH
532 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 4, April 2007
1Current affiliation: Yale University School of Medicine, New
Haven, Connecticut, USA
2Current affiliation: University of Texas Medical Branch, Galveston,
Texas, USA
*University of Texas Medical Branch, Galveston, Texas, USA; and
†Centers for Disease Control and Prevention, Atlanta, Georgia,
USA
It is assumed that humans usually become infected
with hantaviruses and arenaviruses by inhalation of
aerosolized droplets of urine, saliva, or respiratory secre-
tions from infected rodents. Other means of infection
include, but are not limited to, inhalation of dust or other
organic matter contaminated with infectious virus and con-
tact of infectious materials with mucous membranes.
The purpose of this study was to assess the risk for
hantavirus and arenavirus infections among persons who
work in North America and have close physical contact
with neotomine rodents or sigmodontine rodents through
their occupations. These persons include mammalogists,
wildlife biologists, scientists whose research concerns




The persons in this study were participants in a survey
conducted in 1994 by the Centers for Disease Control and
Prevention (CDC). The primary objective of the survey
was to assess the risk for hantavirus infections in persons
whose occupations expose them to rodents. Participation
in the survey was voluntary and entailed completion of a
self-administered questionnaire and donation of a small
volume of venous blood. Most of the 995 participants were
enrolled at 1 of the following: American Society of
Mammalogists meeting (Washington, DC, 1994), Wildlife
Disease Association meeting (Pacific Grove, California,
1994), Southwestern Association of Naturalists meeting
(Emporia, Kansas, 1994), Wildlife Society meeting
(Wenatchee, Washington, 1994), 16th Vertebrate Pest
Conference (Santa Clara, California, 1994), and Colorado
Pest Control Meeting (Denver, Colorado, 1994). The other
participants mailed their completed questionnaires and
serum samples directly to CDC. 
The questionnaire included detailed questions about
previous exposure to rodents, use of personal protective
equipment to minimize exposure to rodent excretions and
secretions, and any previous occurrence of a severe febrile
illness that included shortness of breath. The lifetime num-
ber of rodents handled by a person was measured categor-
ically: I (1–99), II (100–499), III (500–999), IV
(1,000–9,999), V (10,000–49,999), and VI (>50,000). Use
of gloves, protective masks equipped with high efficiency
particulate air (HEPA) filters, and protective eyewear also
was measured categorically: always (>90% of the time),
usually (50%–90% of the time), sometimes (10%–49% of
the time), seldom (<10% of the time), or never.
This study was restricted to the 757 participants in the
CDC survey who had a history of exposure to rodents in
North America and a history of occupational exposure to
deer mice, white-footed mice, California mice, woodrats
(Neotoma spp.), other neotomine rodents, cotton rats
(Sigmodon spp.), oryzomyine rodents (Oryzomys spp. or
Oligoryzomys spp.), or other sigmodontine rodents. Of the
persons included in the study, 699 had worked with rodents
only in North America. The 58 others had worked with
rodents in North America and in South America. The geo-
graphic distribution of exposure to rodents in North
America was Canada (n = 36), Alaska (n = 8), the contigu-
ous United States or District of Columbia (n = 726, Table 1),
Mexico (n = 91), Guatemala (n = 8), Belize (n = 3),
Honduras (n = 3), Costa Rica (n = 21), Nicaragua (n = 4),
and Panama (n = 8). Of the persons included in the study,
468 (61.8%) had worked with rodents in >1 state within the
contiguous United States.
Persons included in the study had worked with rodents
from 1 month to 65 years (mean 12.5 years). The total
number of rodents handled by any 1 person ranged from
category I (1–99) to category VI (>50,000); the median
was IV (1,000–9,999). Of the 757 persons in the study, 751
(99.2%) had handled deer mice, white-footed mice, cotton
rats, oryzomyine rodents, California mice, or woodrats
(Table 2).
HPS was first recognized as a clinical entity in 1993
in the southwestern United States (20). From March 1,
1993, through September 19, 2006, a total of 453 laborato-
ry-confirmed HPS cases were reported to CDC from the
contiguous United States (www.cdc.gov/ncidod/diseases/
hanta/hps/noframes/epislides/episl7.htm). Of these, 259
(57.2%) were reported from 6 states in the southwestern
United States: Colorado (n = 51), New Mexico (n = 71),
Utah (n = 25), Arizona (n = 49), Nevada (n = 18), and
California (n = 45). SNV is the only virus known to cause
HPS in these 6 states. In this study, 387 (51.1%) persons
had worked with rodents in Colorado      (n = 124), New
Mexico (n = 111), Utah (n = 65), Arizona (n = 90), Nevada
(n = 33), or California (n = 169) and had handled deer
mice. The total number of deer mice handled by persons in
this group ranged from I (1–99) to VI (>50,000); the
median was II (100–499).
The geographic range of BAYV includes Georgia,
Louisiana, and Texas (5,15–17), BCCV has been found
only in Florida (4), and the geographic range of NYV
includes New York, Pennsylvania, and Rhode Island
(3,21,22). In this study, 22 persons had worked with
rodents in Georgia (n = 1), Louisiana (n = 2), or Texas
(n = 20) and handled oryzomyine rodents. The total
number of oryzomyine rodents handled by persons in this
group ranged from I (1–99) to IV (1,000–9,999); the medi-
an was I (1–99). Fourteen persons had worked with
rodents in Florida and handled cotton rats. The total num-
ber of cotton rats handled by persons in this group ranged
from I (1–99) to IV (1,000–9,999); the median was II
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(100–499). Eighty-one persons had worked with rodents in
New York (n = 45), Pennsylvania (n = 42), or Rhode Island
(n = 5) and handled white-footed mice. The total number
of white-footed mice handled by persons in this group
ranged from I (1–99) to V (10,000–49,999); the median
was II (100–499).
BCNV virus has been found only in California (18)
and TAMV only in Florida (14); the geographic range of
WWAV and other arenaviruses naturally associated with
woodrats (Neotoma spp.) includes Arizona, California,
Colorado, New Mexico, Oklahoma, Utah, and Texas
(19,23–27). In this study, 31 persons had worked with
rodents in California and handled California mice (P. cali-
fornicus). The total number of California mice handled by
persons in this group ranged from I (1–99) to III
(500–999); the median was I (1–99). As indicated previ-
ously, 14 persons had worked with rodents in Florida and
handled cotton rats. Three hundred and thirty-three per-
sons had worked with rodents in Arizona (n = 87),
California (n = 130), Colorado (n = 76), New Mexico (n =
101), Oklahoma (n = 40), Utah (n = 59), or Texas (n = 101)
and handled woodrats. The total number of woodrats han-
dled by persons in this group ranged from I (1–99) to V
(10,000–49,999); the median was I (1–99).
Lymphocytic choriomeningitis virus (LCMV) is the
only Old World arenavirus species that is enzootic in North
America. The house mouse (Mus musculus) is a member of
the subfamily Murinae, family Muridae (11) and the prin-
cipal host of LCMV. In this study, 526 (69.5%) persons
had worked with house mice. The total number of house
mice handled by persons in this group ranged from I
(1–99) to VI (>50,000); the median was I (1–99).
Of the 757 persons in this study, 735 (97.1%) had
worked with rodents before the discovery of HPS in 1993;
during that time, 504 (68.6%) of them never or infrequent-
ly wore personal protective equipment (gloves, a protective
mask equipped with HEPA filters, and protective eyewear)
when handling rodents. In contrast, only 267 (36.3%) of
these 735 persons never or infrequently wore personal pro-
tective equipment when handling rodents after the discov-
ery of HPS. Use of personal protective equipment by the
other persons in the study both before and after the discov-
ery of HPS depended on the type of equipment.
All unique identifying information was removed from
the serum samples before they were tested for antibodies.
Furthermore, all unique identifying information was
removed from the computer (electronic) records before
analysis of the demographic and serologic data.
Antibody Assays
We tested the serum samples for immunoglobulin G
(IgG) against SNV, WWAV, GTOV, and LCMV by using
ELISA, as described (24,28). The SNV antigen was an
RESEARCH
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Escherichia coli–expressed recombinant SNV nucleocap-
sid protein that is highly cross-reactive with other
neotomine rodent-associated hantaviruses and with sig-
modontine rodent-associated hantaviruses in the ELISA
used in this study (T.G. Ksiazek, unpub. data). The control
(comparison) antigen for the SNV IgG ELISA was an E.
coli–expressed recombinant protein that is antigenically
unrelated to the SNV nucleocapsid protein. The arenavirus
antigens were detergent lysates of Vero E6 cells infected
with WWAV strain AV 9310135, GTOV strain INH-95551,
or LCMV strain Armstrong. WWAV is highly cross-reac-
tive with BCNV and TAMV in the ELISA used in this
study (M.L. Milazzo, unpub. data). Collectively, WWAV,
GTOV, and LCMV represent the 3 major antigen groups in
the family Arenaviridae, as defined by ELISA (19). The
control antigens for the arenavirus IgG assays were deter-
gent lysates of uninfected Vero E6 cells. The working con-
centrations of the SNV, GTOV, and LCMV antigens and
the corresponding control antigens were determined by
checkerboard titration against convalescent-phase serum
samples from humans infected with SNV, GTOV, and
LCMV, respectively. The working concentrations of the
WWAV antigen and the corresponding control antigen
were determined by checkerboard titration against a mouse
ascitic fluid against WWAV strain AV 9310135. Serial 4-
fold dilutions (from 1:100 through 1:6,400) of each serum
sample were tested against the 4 test antigens and 4 control
antigens. Antibody bound to antigen was detected by using
a goat anti-human IgG (gamma chain–specific) peroxidase
conjugate (Kirkegaard and Perry Laboratories,
Gaithersburg, MD, USA). Optical densities (OD) at 405
nm (reference = 490 nm) were measured with a Dynex
MRX II microplate reader (Dynatech Industries, Inc.,
McLean, VA, USA). The adjusted OD (AOD) of a serum-
antigen reaction was the OD of the well coated with the
test antigen minus the OD of the well coated with the con-
trol antigen. A sample was considered positive if the AOD
at 1:100 was >0.200, the AOD at 1:400 was >0.200, and
the sum of the AODs for the series of 4-fold dilutions
(from 1:100 through 1:6,400) was >0.900. These criteria
for positivity were based on the results of previous work
with the test antigens and control antigens. The antibody
titer of a positive sample was the reciprocal of the highest
dilution of that sample for which the AOD was >0.200.
Results
Antibodies against SNV were detected in 4 (0.5%) of
the 757 persons in the study. Antibody titers were 1,600 in
2 persons and ≥6,400 in the other 2 persons. The total years
worked with rodents and the lifetime number of rodents
handled by the 4 antibody-positive persons were 9.0–30.0
(mean 21.3) and IV (1,000–9,999) to V (10,000–49,999),
respectively. Two of the antibody-positive persons had
worked with rodents only within the contiguous United
States (specifically Arkansas, Arizona, Colorado, Iowa,
Kansas, Michigan, Oklahoma, South Carolina, and/or
Texas), 1 had worked with rodents in Arizona, Colorado,
New Mexico, Utah, Texas, and Mexico, and 1 had worked
with rodents in Michigan, Pennsylvania, Mexico, Costa
Rica, and Argentina. All 4 antibody-positive persons had
handled deer mice, white-footed mice, other neotomine
rodents, cotton rats, and other sigmodontine rodents.
Those who had worked in South Carolina or Argentina
also had handled oryzomyine rodents. All 4 antibody-pos-
itive persons reported that they had never worn a protec-
tive mask or protective eyewear when handling rodents
before the discovery of HPS. One reported having been
hospitalized for an illness characterized by fever,
headache, and severe shortness of breath (symptoms sug-
gestive of HPS). This person had worked with rodents only
within the contiguous United States.
Antibodies against WWAV or GTOV were detected in
2 (0.3%) of the 757 persons in the study. Antibodies
against WWAV (antibody titer = 1,600) but not GTOV
were detected in a person who had worked with rodents in
Texas and Wisconsin and handled woodrats, other
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neotomine rodents, and sigmodontine rodents. Antibodies
against GTOV (antibody titer = 1,600) but not WWAV
were detected in a person who had worked with rodents in
Pennsylvania, Utah, and Wyoming and handled white-
footed mice, other neotomine rodents, cotton rats, and
other sigmodontine rodents. The lifetime number of
rodents handled by the 2 antibody-positive persons were
III (500–999) and IV (1,000–9,999), respectively. Both
reported that they had never worn a protective mask or
protective eyewear when handling rodents before the dis-
covery of HPS. Antibodies against LCMV were found in
none of the 757 persons in this study.
Discussion
Previously published studies found no antibodies
against SNV in 583 persons who worked in Arizona or
New Mexico in occupations that potentially exposed them
to rodents or rodent droppings (29,30) and no antibodies
against SNV or WWAV in 72 persons in California whose
occupations entailed close physical contact with rodents
(31). Limited seroprevalence studies found antibodies
against LCMV in up to 5.1% of healthy persons in the
United States (32,33). If one discounts fatal infections and
assumes that IgG against SNV and other hantaviruses is
measurable many years after recovery from infection, the
results of this study indicate that the risk for infection with
hantaviruses usually is low in persons whose occupations
entail close physical contact with neotomine rodents or
sigmodontine rodents in North America. Similarly, the
study results indicate that the risk for infection with are-
naviruses usually is low in persons whose occupations
entail close physical contact with neotomine rodents or
sigmodontine rodents in North America
Some hantaviruses and arenaviruses appear to be
restricted to small areas within the geographic ranges of
the rodent species that serve as their natural reservoirs. For
example, BCCV and TAMV have been found only in
southern Florida (4,14), yet the geographic range of S.
hispidus extends from Arizona, Nebraska, and Virginia
through northeastern Mexico (11). Furthermore, the preva-
lence of infected rodents can vary widely even in a small
area (23,34). Thus, the low prevalence of antibodies
against SNV and against the arenaviruses included in this
study could be because few of the rodents handled by the
757 persons in the study were infected with a hantavirus or
arenavirus. Other explanations for the low prevalence of
antibodies against SNV, WWAV, GTOV, and LCMV in this
study are because the circumstances under which or the
manner in which the rodents were handled did not favor
rodent-to-human virus transmission or because tissues,
secretions, and excretions from infected rodents are not
highly infectious to humans.
Antibodies against SNV were detected in 3 (0.8%) of
the 387 persons in this study who had worked with rodents
in Colorado, New Mexico, Utah, Arizona, Nevada, or
California and who had handled deer mice. Antibodies to
SNV also were detected in 1 (1.2%) of the 81 persons who
had worked in New York, Pennsylvania, or Rhode Island
and who had handled white-footed mice. The antibodies
against SNV in the 3 antibody-positive persons who had
worked in the southwestern United States could be a con-
sequence of infection with SNV. The antibodies against
SNV in the person who had worked in Pennsylvania could
be a result of infection with NYV.
Of the 453 laboratory-confirmed HPS cases men-
tioned previously, 160 (35.3%) were fatal. Together, the
high case-fatality ratio of HPS in North America, the lack
of a vaccine against HPS, and the lack of a specific thera-
py for HPS should motivate persons to minimize their risk
for infection while working in the field, classroom, or lab-
oratory with rodents potentially infected with hantaviruses,
especially those viruses known to cause HPS. Published
guidelines for safely working with rodents potentially
infected with hantaviruses include using protective gloves,
respirators fitted with HEPA filters, and protective eyewear
(35). None of the 4 persons in the study who were anti-
body-positive against SNV had worn gloves, masks, or
protective eyewear when handling rodents before the dis-
covery of HPS.
The use of personal protective equipment in the field
may seem cumbersome. However, 2 recent HPS cases, 1
fatal, underscore the need to use appropriate personal pro-
tective equipment and follow recommended safety proce-
dures when working with rodents potentially infected with
hantaviruses that have been causally associated with HPS.
The fatal case was in a graduate student who was studying
the effects of forest management practices on small mam-
mal populations in West Virginia (36). The nonfatal case
was in a field technician who was trapping rodents as part
of a forest health study in California (37). HPS has been
reported in other persons whose occupations entailed close
physical contact with wild rodents (38,39).
The person in this study who was antibody-positive
against WWAV had worked with rodents in Texas and han-
dled woodrats. Antibodies against WWAV strain AV
9310135 have been found in southern plains woodrats
(Neotoma micropus) captured in western Texas and in
northern Texas (M.L. Milazzo, unpub. data), and are-
naviruses antigenically closely related to WWAV strain AV
9310135 have been isolated from southern plains woodrats
captured in southern Texas (27,40). Thus, the antibodies
against WWAV in this person could be a result of an are-
navirus infection acquired from a woodrat captured in
Texas.
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When examined by antibody-antigen binding assays
such as the ELISA, GTOV is distinct from the 3 North
American arenaviruses and highly cross-reactive with
JUNV, MACV, and SABV (19). Thus, the antibodies
against GTOV in the person in this study could be a result
of an arenavirus infection acquired while traveling in
South America. Alternatively, the antibodies could be a
result of infection with a North American arenavirus that is
antigenically more closely related to GTOV than to BCNV,
TAMV, or WWAV.
Recently, antibodies against GTOV but not WWAV or
LCMV were detected in 3 peromyscine rodents
(Peromyscus sp.) captured in southern Mexico (M.L.
Milazzo, unpub. data). The antibodies against GTOV in
these 3 rodents are the first evidence that an arenavirus
antigenically distinct from BCNV, TAMV, WWAV, and
LCMV exists in North America and support the idea that
the infection in the antibody-positive person in this study
was a result of an arenavirus infection acquired in North
America.
National Institutes of Health grant AI-41435 provided finan-
cial support for the portion of this study conducted by M.L.M.
and C.F.F.
This study was approved by the Committee for the
Protection of Human Subjects, Centers for Disease Control and
Prevention. Written informed consent was obtained from all par-
ticipants in accordance with Title 45, Part 46 of the Code of
Federal Regulations.
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Medical Branch. His research interests include the epidemiology
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to the Americas.
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